Nuclear Startup Oklo Reports Wider Annual Loss as R&D Costs Surge
Pre-revenue Oklo reports wider-than-expected 2025 loss of $0.72/share. Stock struggles persist despite regulatory progress focus.
Markets move fast. You should move faster. Be the first to know when deals break, stocks move, or biotech headlines hit. Sign up to get breaking news alerts the moment they happen.
Pre-revenue Oklo reports wider-than-expected 2025 loss of $0.72/share. Stock struggles persist despite regulatory progress focus.
Lululemon projected conservative 2026 revenue of $11.35B–$11.50B (2–4% growth) and EPS of $12.10–$12.30, below Wall Street expectations. Shares dropped as the brand hunts for a new CEO amid founder Chip Wilson’s board push, quality complaints, and rising competition.
Amazon’s (AMZN) Andy Jassy said during an internal employee meeting that AI could push AWS annual sales to $600B within a decade—doubling his prior $300B forecast—from the current $128.7B.
Leaked Publicis memo urges clients to steer clear of The Trade Desk DSP following failed third-party audit on fees, opt-ins, and transparency. TTD denies claims.
Executives highlight strong execution and new multibillion OCS pact at OFC 2026—replacing $400M guidance for years of revenue growth in cloud/AI networking.
Nebius stock plunged up to 10% after announcing a $3.75 billion offering of convertible senior notes due 2031 and 2033. The funds will finance data center builds, GPU purchases, and AI cloud expansion.